Literature DB >> 25510739

Prevalence of Coinfection with Gastric Non-Helicobacter pylori Helicobacter (NHPH) Species in Helicobacter pylori-infected Patients Suffering from Gastric Disease in Beijing, China.

Jie Liu1,2, Lihua He1,2, Freddy Haesebrouck3, Yanan Gong1,2, Bram Flahou3, Qizhi Cao1,2, Jianzhong Zhang1,2.   

Abstract

BACKGROUND: The Helicobacter heilmannii sensu lato (H. heilmannii s.l.) group consists of long, spiral-shaped bacteria naturally colonizing the stomach of animals. Moreover, bacteria belonging to this group have been observed in 0.2-6% of human gastric biopsy specimens, and associations have been made with the development of chronic gastritis, peptic ulceration, and gastric MALT lymphoma in humans.
MATERIALS AND METHODS: To gain insight into the prevalence of H. heilmannii s.l. infections in patients suffering from gastric disease in China, H. heilmannii s.l. species-specific PCRs were performed on DNA extracts from rapid urease test (RUT)-positive gastric biopsies from 1517 patients followed by nucleotide sequencing. At the same time, Helicobacter pylori cultivation and specific PCR was performed to assess H. pylori infection in these patients.
RESULTS: In total, H. heilmannii s.l. infection was detected in 11.87% (178/1499) of H. pylori-positive patients. The prevalence of H. suis, H. felis, H. bizzozeronii, H. heilmannii sensu stricto (s.s.), and H. salomonis in the patients was 6.94%, 2.20%, 0.13%, 0.07%, and 2.54%, respectively. Results revealed that all patients with H. heilmannii s.l. infection were co-infected with H. pylori, and some patients were co-infected with more than two different Helicobacter species.
CONCLUSIONS: Helicobacter heilmannii s.l. infections are fairly common in Chinese patients. This should be kept in mind when diagnosing the cause of gastric pathologies in patients. Helicobacter suis was shown to be by far the most prevalent H. heilmannii s.l.species.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Gastric biopsy; H. heilmannii s.l; H. pylori; coinfection; prevalence

Mesh:

Substances:

Year:  2014        PMID: 25510739     DOI: 10.1111/hel.12201

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  16 in total

1.  Helicobacter Species Identified in Captive Sooty Mangabeys (Cercocebus atys) with Metastatic Gastric Adenocarcinoma.

Authors:  Michael Y Esmail; Rebecca Bacon; Alton G Swennes; Yan Feng; Zeli Shen; AnaPatricia Garcia; Prachi Sharma; Joyce Cohen; James G Fox
Journal:  Helicobacter       Date:  2015-10-19       Impact factor: 5.753

Review 2.  A comprehensive update: gastrointestinal microflora, gastric cancer and gastric premalignant condition, and intervention by traditional Chinese medicine.

Authors:  Yuting Lu; Huayi Liu; Kuo Yang; Yijia Mao; Lingkai Meng; Liu Yang; Guangze Ouyang; Wenjie Liu
Journal:  J Zhejiang Univ Sci B       Date:  2022-01-15       Impact factor: 3.066

3.  Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.

Authors:  Hidehiko Takigawa; Ryo Yuge; Satoshi Masaki; Rina Otani; Hiroki Kadota; Toshikatsu Naito; Ryohei Hayashi; Yuji Urabe; Shiro Oka; Shinji Tanaka; Kazuaki Chayama; Yasuhiko Kitadai
Journal:  Gastric Cancer       Date:  2021-02-27       Impact factor: 7.370

4.  Gastric Juice-Based Real-Time PCR for Tailored Helicobacter Pylori Treatment: A Practical Approach.

Authors:  Xianhui Peng; Zhiqiang Song; Lihua He; Sanren Lin; Yanan Gong; Lu Sun; Fei Zhao; Yixin Gu; Yuanhai You; Liya Zhou; Jianzhong Zhang
Journal:  Int J Med Sci       Date:  2017-05-15       Impact factor: 3.738

5.  Non-pylori Helicobacters (NHPHs) Induce Shifts in Gastric Microbiota in Helicobacter pylori-Infected Patients.

Authors:  Xianhui Peng; Liya Zhou; Yanan Gong; Zhiqiang Song; Lihua He; Sanren Lin; Jianzhong Zhang
Journal:  Front Microbiol       Date:  2017-06-08       Impact factor: 5.640

Review 6.  Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models.

Authors:  Michael D Burkitt; Carrie A Duckworth; Jonathan M Williams; D Mark Pritchard
Journal:  Dis Model Mech       Date:  2017-02-01       Impact factor: 5.758

7.  The Resolution of Helicobacter suis-associated Gastric Lesions after Eradication Therapy.

Authors:  Satoru Nakagawa; Tadashi Shimoyama; Masahiko Nakamura; Daisuke Chiba; Hidezumi Kikuchi; Manabu Sawaya; Daisuke Chinda; Tatsuya Mikami; Shinsaku Fukuda
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

8.  Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hidehiko Takigawa; Satoshi Masaki; Toshikatsu Naito; Ryo Yuge; Yuji Urabe; Shinji Tanaka; Kazuhiro Sentani; Taiji Matsuo; Keisuke Matsuo; Kazuaki Chayama; Yasuhiko Kitadai
Journal:  Cancer Med       Date:  2019-06-18       Impact factor: 4.452

9.  In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.

Authors:  Qian Rong; Min Xu; Qi Dong; Yuli Zhang; Yinglun Li; Gang Ye; Ling Zhao
Journal:  BMC Complement Altern Med       Date:  2016-08-30       Impact factor: 3.659

10.  Prevalence of non Helicobacter pylori gastric Helicobacters in Iranian dyspeptic patients.

Authors:  Shakiba Shafaie; Hami Kaboosi; Fatemeh Peyravii Ghadikolaii
Journal:  BMC Gastroenterol       Date:  2020-06-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.